FIELD: chemistry.
SUBSTANCE: invention relates to a ligand of metal complex. A ligand of metal complex having the following structure or
wherein Z is CH2=; m=0 or 1, n=0 or 1; when m=0, X is HN, C1-C20-alkylimino or C6-C20-arylamino; when m=1, X is CH2; X is HN or C1-C20-alkylimino;
EFFECT: transition metal complexes offering high activity and selectivity for ROMP and RCM reactions.
11 cl, 13 tbl, 118 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PRODUCING TERTIARY ALCOHOLS BY REACTION OF ARYLOLEFINS WITH AlCl AND KETONES UNDER INFLUENCE OF CpZrCl CATALYST | 2023 |
|
RU2813640C1 |
AMIDE DERIVATIVES OF PYROSOL | 2015 |
|
RU2658827C2 |
AGONISTS OF RECEPTOR OF PEPTIDE-1, SIMILAR TO GLUCAGONE, THEIR OBTAINING AND APPLICATION | 2003 |
|
RU2342368C2 |
SUBSTITUTED BIARYL COMPOUNDS OR SUBSTITUTED PYRIDINES AND PHARMACEUTICAL COMPOSITIONS BASED ON THEREOF | 1997 |
|
RU2195443C2 |
VITAMIN D PRECURSORS, METHOD FOR PREPARATION THEREOF, AND INTERMEDIATES | 2000 |
|
RU2247710C2 |
CHIRAL 18-SULPHO-DERIVATIVES OF DEHYDROABIETANE AND A METHOD FOR PRODUCTION THEREOF | 2020 |
|
RU2726793C1 |
ACHIRAL BIDENTATE P,N-LIGANDS AND METHOD FOR THEIR PREPARING | 2003 |
|
RU2239639C1 |
PESTICIDE COMPOSITIONS AND RELATED METHODS | 2013 |
|
RU2654327C2 |
DERIVATIVES OF TETRAHYDROISOQUINOLINE, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF, METHOD FOR INHIBITION OF SYNAPTIC UPTAKE OF DOPAMINE AND TREATMENT METHOD | 2000 |
|
RU2293728C2 |
COMPOUNDS, PHARMACEUTICAL COMPOSITION, METHOD FOR PREVENTING NERVOUS CELL DEATH, METHOD FOR PROPHYLAXIS | 2001 |
|
RU2230060C2 |
Authors
Dates
2015-04-10—Published
2010-12-30—Filed